Alessandra Milanesi

Pavia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS study.

Prognostic value of quantifying vascular inflammation through ultrasound in patients with giant cell arteritis: the MAGiCUS study.

Journal: Rheumatology (Oxford, England)

Published: January 23, 2026

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Risk of intestinal involvement in mucocutaneous-onset Behçet's disease: data from the AIDA network registry.

Journal: Frontiers in immunology

Published: December 30, 2025

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Journal: Frontiers in immunology

Published: November 24, 2025

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

Journal: Seminars in arthritis and rheumatism

Published: November 14, 2025

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Journal: Frontiers in immunology

Published: September 19, 2025

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

Journal: Ophthalmology and therapy

Published: August 22, 2025

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

The Risk of Developing Ocular Involvement Among Behçet's Disease Patients Presenting with Mucocutaneous Involvement at Disease Onset: Data from the International AIDA Network Behçet's Disease Registry.

Journal: Ophthalmology and therapy

Published: August 22, 2025

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

Clinical and laboratory markers to distinguish VEXAS from Schnitzler's syndrome: data from the AIDA network registries.

Journal: Frontiers in medicine

Published: August 01, 2025

Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study.

Long-term maintenance of remission with spacing of rituximab infusions based on the individualised patient risk profile in ANCA-associated vasculitis: a pilot study.

Journal: RMD open

Published: May 06, 2025

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

Journal: Rheumatology (Oxford, England)

Published: April 17, 2025

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.

Journal: Rheumatology (Oxford, England)

Published: April 17, 2025

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.

Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.

Journal: Rheumatology (Oxford, England)

Published: February 17, 2025

Showing 1-12 of 27

Last Updated: 09/26/2026